Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Pfizer Inc.
IndexDJIA S&P500 P/E18.74 EPS (ttm)1.65 Insider Own0.10% Shs Outstand6.39B Perf Week3.45%
Market Cap197.69B Forward P/E13.45 EPS next Y2.30 Insider Trans7.50% Shs Float6.39B Perf Month-1.81%
Income11.38B PEG7.07 EPS next Q0.55 Inst Own71.60% Short Float0.84% Perf Quarter-0.29%
Sales51.58B P/S3.83 EPS this Y37.50% Inst Trans0.02% Short Ratio1.85 Perf Half Y3.34%
Book/sh11.20 P/B2.76 EPS next Y2.91% ROA23.20% Target Price34.15 Perf Year2.76%
Cash/sh5.07 P/C6.10 EPS next 5Y2.65% ROE52.60% 52W Range26.47 - 32.96 Perf YTD1.78%
Dividend1.04 P/FCF20.34 EPS past 5Y6.80% ROI10.50% 52W High-6.19% Beta0.74
Dividend %3.36% Quick Ratio2.10 Sales past 5Y1.30% Gross Margin81.90% 52W Low16.79% ATR0.57
Employees77700 Current Ratio2.40 Sales Q/Q-5.60% Oper. Margin33.40% RSI (14)47.02 Volatility1.31% 1.73%
OptionableYes Debt/Eq0.48 EPS Q/Q37.50% Profit Margin80.30% Rel Volume0.70 Prev Close31.00
ShortableYes LT Debt/Eq0.40 EarningsMay 05 BMO Payout16.00% Avg Volume28.89M Price30.92
Recom2.20 SMA20-1.00% SMA50-2.27% SMA2002.90% Volume20,387,734 Change-0.26%
02-Jul-13Downgrade Standpoint Research Hold → Sell $24
15-Apr-13Reiterated Barclays Equal Weight $25 → $32
30-Jan-13Reiterated UBS Buy $29 → $31
30-Jan-13Reiterated Argus Buy $28 → $32
22-Jan-13Reiterated Barclays Equal Weight $24 → $25
27-Nov-12Downgrade MKM Partners Buy → Neutral $29 → $25
05-Oct-12Reiterated MKM Partners Buy $27 → $29
01-Nov-11Downgrade Standpoint Research Buy → Hold
07-Oct-11Initiated MKM Partners Buy $20.50
14-Sep-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
10-Aug-11Upgrade Argus Hold → Buy $21
05-Aug-11Upgrade Standpoint Research Hold → Buy $21
14-Mar-11Downgrade Standpoint Research Buy → Hold
03-Nov-10Downgrade Argus Buy → Hold
21-May-10Initiated Jefferies Buy $17.80
16-Dec-09Initiated UBS Buy
27-Apr-09Initiated Standpoint Research Buy $20
12-Feb-09Upgrade Leerink Swann Mkt Perform → Outperform
09-Feb-09Upgrade UBS Neutral → Buy
02-Feb-09Upgrade Credit Suisse Neutral → Outperform
24-Apr-14 03:38AM  [video] Why Is the Drug Industry in a Deal Frenzy? at Bloomberg
23-Apr-14 06:34PM  Will These 3 Dividend Stocks Impress Investors This Earnings Season? at Motley Fool
05:20PM  Encouraging Results from Pfizer's Xeljanz Zacks
04:52PM  This company just had the best new drug launch of all-time Talking Numbers
02:18PM  [$$] More Consolidation in Cancer Space Expected at The Wall Street Journal
01:12PM  Your first trade for Thursday at CNBC
12:58PM  [video] FMHR Final Trade: PFE, FB & more at CNBC
11:00AM  [video] Pharma deal frenzy at CNBC
10:25AM  Pharma Drama: Pfizer Fails to Woo AstraZeneca; Valeant Pursues Allergan at Wall St. Cheat Sheet
08:40AM  Amgen's Q1 Earnings Decline Y/Y Zacks
08:36AM  Alnylam Strikes Back: Comments From CEO John Maraganore at Forbes
07:32AM  Spheras Hershkovitz Discusses Novartis, Glaxo Deal (Audio) at Bloomberg
06:21AM  Celgene to Rise Like a Phoenix: Opinion at TheStreet
12:08AM  Asia shares mixed on lackluster China data AP
12:01AM  Drugmakers in Deal Frenzy Seek to Be First, Best or Gone Bloomberg
22-Apr-14 07:15PM  [video] Unraveling the Seismic Shifts in Big Pharma at Bloomberg
06:36PM  Drugmakers Prod European Stocks To Post-Easter Rally at Investor's Business Daily
06:31PM  A Doozy of a Pharma Rumor at Motley Fool
06:11PM  Valeant's Bid For Allergan Boosts Ethical Drug Stocks at Investor's Business Daily
04:09PM  Billionaire Ken Fisher's Top Stock Picks at Motley Fool
02:38PM  Big Pharma Seeking to Reduce Risk, Boost Profits Thru Deals at Fox Business
01:10PM  [video] How to play big pharma at CNBC
01:02PM  3 Health Care Stocks Moving The Sector Upward at TheStreet
12:02PM  [video] Pharma's big deal frenzy at CNBC
10:58AM  Today's Health-Care Stocks to Watch: Allergan, Inc., AstraZeneca, Pfizer, and Valeant Pharmaceuticals at Motley Fool
10:48AM  [video] Allergan, Valeant perfect match: CEO at CNBC
10:25AM  Pfizer, AstraZeneca Are Ripe for Pharma Deal Alone or Together Bloomberg
09:50AM  Big pharma deals signal next phase of growth Hot Stock Minute
09:25AM  Stock Downgrades: A Money Tree No More, Zillow Weeps Like a Willow at Minyanville
08:00AM  Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis Business Wire
05:43AM  European Markets Gain; Drug-Makers in Focus Morningstar
05:29AM  Big Pharma's Deal Frenzy at The Wall Street Journal
03:51AM  Pfizer, AstraZeneca Are Ripe for Pharma Deal: Real M&A Bloomberg
03:51AM  Pfizer, AstraZeneca Are Ripe for Pharma Deal: Real M&A at Bloomberg
03:51AM  Pfizer, AstraZeneca Are Ripe for Pharma Deal Alone or Together Bloomberg
03:07AM  AstraZeneca Rises on Reported Talks With Pfizer Over Deal at Bloomberg
12:03AM  Botox maker Allergan draws bid from Valeant AP
21-Apr-14 08:16PM  Pfizer Agrees to Pay $190 Million to Settle Neurontin Case at Bloomberg
07:40PM  The Biggest Biotech Wins of the Week at Motley Fool
06:32PM  Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try? at Motley Fool
06:26PM  Valeant to bid for Botox maker Allergan AP
06:24PM  Pfizer-AstraZeneca deal? Not as crazy as it sounds at CNBC
05:40PM  Is Pfizer a Good Portfolio Play? at Wall St. Cheat Sheet
04:50PM  Pfizer agrees to $190 mln settlement over generic Neurontin Reuters
04:40PM  On The Fly: Closing Wrap at theflyonthewall.com
04:21PM  [video] The Top Ten Stocks for April 21 at Bloomberg
04:15PM  Pfizer Said to Have Held Talks to Acquire AstraZeneca at Bloomberg
04:15PM  How Johnson & Johnson Became A Household Name at Investopedia
04:08PM  [$$] AstraZeneca Shares Up on Speculation of Talks With Pfizer at The Wall Street Journal
03:35PM  Supreme Court Denies Teva's Request Zacks
03:30PM  Is Pfizer Eyeing AstraZeneca? Zacks
02:38PM  Pfizer's Missed Megadeal Sparks the Dow's Rise at Motley Fool
02:32PM  Warfarin's Loss is Johnson & Johnson's Gain at Motley Fool
02:00PM  Dow Today: Pfizer (PFE) Higher at TheStreet
01:45PM  Why Pfizer (PFE) Stock Is Up Today at TheStreet
01:25PM  What a Combined Pfizer and AstraZeneca Would Look Like, and Face at 24/7 Wall St.
01:17PM  Spurning Merger Approaches, AstraZeneca Pursues Own Path at New York Times
12:47PM  On The Fly: Midday Wrap at theflyonthewall.com
12:44PM  Nothing Generic About Mylan at Forbes
12:37PM  [video] This is Not a Stock Market, but a Market for Stocks at TheStreet
12:09PM  Interesting August Stock Options For PFE at TheStreet
12:01PM  Investors drive up AstraZeneca despite questions over potential Pfizer deal at MarketWatch
11:28AM  August 16th Options Now Available For Pfizer (PFE) at TheStreet
11:25AM  Could Pfizer Be Considering a Grab for AstraZenecas Cancer Pipeline? at Wall St. Cheat Sheet
11:13AM  Pfizer, AstraZeneca Rise On Report Of Merger Talks at Investor's Business Daily
11:03AM  Dow Rises Slightly on Pfizer-AstraZeneca Reports; Disney Gives up Ground at Motley Fool
11:00AM  [video] Pfizer Informal Talks With AstraZeneca Broke Off at Bloomberg
10:48AM  Should Pfizer Attempt To Acquire AstraZeneca? at Seeking Alpha
10:18AM  Would Pfizer Buying AstraZeneca Actually Make Sense? at Motley Fool
10:18AM  Analysts differ on chances of Pfizer interest in AstraZeneca at theflyonthewall.com
10:03AM  [video] Pfizer Ready to Spend Cash and Sarepta Readies MS Drug at TheStreet
08:54AM  Today's Market: Other Potential Buyout Targets For Pfizer at Seeking Alpha
08:19AM  Why AstraZeneca (AZN) Stock Is Surging This Morning at TheStreet
08:02AM  Busy week for the markets; Report: talks of $100B deal between two drug giants; America's fastest-shrinking cities Hot Stock Minute
08:00AM  Promotional Campaigns, Equity Awards, Stock Price Movements, New Launches, and Company Events - Analyst Notes on Pfizer, Intuitive Surgical, HCA Holdings, General Electric and John Deere PR Newswire
07:47AM  Morning Movers: AstraZeneca Gains on Acquisition Discussions; Sarepta Surges at Barrons.com
07:04AM  Potential Impact On R&D Of A Pfizer Takeover Of AstraZeneca at Forbes
06:55AM  AstraZeneca cancer pipeline seen as draw for Pfizer Reuters
06:30AM  [video] BP Balks at Spill Studies Bill at Bloomberg
20-Apr-14 08:55PM  Pfizer Said to Have Held Now-Dormant Talks to Buy AstraZeneca Bloomberg
11:03AM  Pfizer Made $101 Billion Bid for AstraZeneca, Times Says at Bloomberg
10:16AM  Pfizer considers $100B bid for AstraZeneca: report at CNBC
10:04AM  Pfizer considers $100 billion bid for AstraZeneca: report Reuters
10:00AM  Pfizer considers $100 bln bid for AstraZeneca - report Reuters
06:44AM  Pfizer mulls $100 bln bid for AstraZeneca - report Reuters
18-Apr-14 01:20PM  Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting of Shareholders Business Wire
17-Apr-14 02:32PM  Johnson & Johnson's 3 Major Strengths at Motley Fool
01:08PM  FDA wants stronger warning labels for long-acting opioids Reuters
12:56PM  Teva settles patent suit with Pfizer over Celebrex Reuters
12:30PM  Midday movers: Weibo, Sabre, Goldman Sachs & More at CNBC
11:34AM  AbbVie Candidate in Pivotal Study Zacks
10:45AM  Teva, Pfizer settle patent lawsuit over blockbuster painkiller Reuters
09:48AM  [$$] Teva Can Release Generic Celebrex by Year's End at The Wall Street Journal
09:18AM  Teva, Pfizer settle patent lawsuit over painkiller Celebrex Reuters
06:39AM  GSK, facing bribery claims, battles to build new sales model Reuters
16-Apr-14 07:01PM  New kind of trial aims to speed cancer drug development Reuters
06:30PM  The Biggest Biotech Wins of the Week at Motley Fool
02:28PM  Will Recent News Hurt GlaxoSmithKline? at Wall St. Cheat Sheet
01:38PM  Dear Jenny McCarthy, Here's How Many Lives Could Be Saved Cheaply By Making Vaccines More Widely Available at Forbes
12:55PM  Cancer Doctors Plan to Compare Value of Expensive Drugs Bloomberg
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company primarily offers biopharmaceutical products, including Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.82131,8104,062,225356,451Jan 14 07:13 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.8628,190869,817328,261Jan 14 07:13 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Option Exercise26.2092,0002,410,400152,447Nov 18 03:31 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Sale32.1092,0002,953,06360,447Nov 18 03:31 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerNov 01Sale31.2010,000311,985174,841Nov 04 03:59 PM
READ IAN CChairman & CEOOct 28Option Exercise26.20338,0008,855,6001,412,267Oct 29 05:44 PM
READ IAN CChairman & CEOOct 28Sale30.57338,00010,331,3151,074,267Oct 29 05:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentSep 16Option Exercise26.0660,9001,587,198150,617Sep 18 04:27 PM
LANKLER DOUGLAS MExecutive Vice PresidentSep 16Sale28.7060,9001,748,02589,717Sep 18 04:27 PM
Lewis-Hall Freda CExecutive Vice PresidentSep 16Sale28.7038,4611,103,831118,383Sep 18 04:20 PM
CORNWELL W DONDirectorAug 12Buy29.0975822,0502,217Aug 13 03:58 PM
CORNWELL W DONDirectorAug 12Sale29.0975822,0501,459Aug 13 03:58 PM
HILL CHARLES HExecutive Vice PresidentJul 31Option Exercise26.0496,5002,512,460171,362Aug 01 05:39 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerJul 31Sale29.6314,688435,180183,703Aug 01 05:39 PM
HILL CHARLES HExecutive Vice PresidentJul 31Sale29.6496,5002,860,43474,862Aug 01 05:39 PM
SCHULMAN AMY WExecutive Vice PresidentMay 15Sale29.3670,0002,055,389223,497May 16 08:18 PM
READ IAN CChairman & CEOMay 15Sale29.3969,9002,054,3351,061,463May 16 08:10 PM
DAMELIO FRANK AExecutive Vice PresidentMay 15Sale29.33100,0002,932,863485,682May 16 07:24 PM